NCT02125214

Brief Summary

Temporal dynamics of the EEG microstates show scale-free monofractal properties. This means that information is encoded in the same way at different scales. It may be postulated that these monofractal properties of the EEG microstate sequences constitute a necessary prerequisite of consciousness. We postulate that clinical variations of consciousness may also be linked to alterations of fractal properties of EEG microstates.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2014

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2014

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

April 24, 2014

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 29, 2014

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2015

Completed
Last Updated

June 1, 2015

Status Verified

May 1, 2015

Enrollment Period

1.2 years

First QC Date

April 24, 2014

Last Update Submit

May 29, 2015

Conditions

Keywords

consciousness, anesthesia, electroencephalogram, microstate, long-range dependency

Outcome Measures

Primary Outcomes (1)

  • EEG microstates

    Assess the alteration of temporal organization of EEG microstate sequences during propofol-induced loss of consciousness.

    45 minutes

Study Arms (1)

ASA 1-2

EXPERIMENTAL

ASA 1-2 patients 20-40 yr

Device: Target Controlled Infusion system (Orchestra Base Primea, Fresenius, France)

Interventions

Intravenous induction with propofol using the pharmacokinetic model by Schnider et al. The initial cerebral concentration will be 0.5 µg ml-1, which will be increased stepwise by 1.0 µg ml-1 until 2.5 µg ml-1, and then by 0.5 µg ml-1 until loss of consciousness

ASA 1-2

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Adult patients (age between 18 and 40 years)
  • Right-handed
  • American Society of Anesthesiology (ASA) status I-II
  • Scheduled for elective surgery requiring a general anaesthetic
  • Able to read and understand the information sheet and to sign and date the consent form.

You may not qualify if:

  • Patients with significant cardio-respiratory or other end-organ disease (renal or hepatic disease influencing metabolism or elimination of study drugs).
  • Patients with depression, neurological or psychiatry disorders.
  • Dementia or inability to understand the study informed consent.
  • Patients with a history of oesophageal reflux, hiatus hernia or any other condition requiring rapid sequence induction of anaesthesia.
  • History of drug (opioids) or alcohol abuse.
  • Patients with a body mass index \>30 kg m-2.
  • Left handed patients
  • History of allergy or hypersensitivity to propofol.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospitals of Geneva

Geneva, Canton of Geneva, 1206, Switzerland

Location

Related Publications (1)

  • Britz J, Van De Ville D, Michel CM. BOLD correlates of EEG topography reveal rapid resting-state network dynamics. Neuroimage. 2010 Oct 1;52(4):1162-70. doi: 10.1016/j.neuroimage.2010.02.052. Epub 2010 Feb 24.

    PMID: 20188188BACKGROUND

MeSH Terms

Conditions

Unconsciousness

Condition Hierarchy (Ancestors)

Consciousness DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Martin Tramer, MD, DPhil

    University Hospitals of Geneva, Department of Anesthesiology

    STUDY DIRECTOR
  • Julien Maillard, MD

    University Hospitals of Geneva, Department of Anesthesiology

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Medical Doctor

Study Record Dates

First Submitted

April 24, 2014

First Posted

April 29, 2014

Study Start

January 1, 2014

Primary Completion

April 1, 2015

Study Completion

April 1, 2015

Last Updated

June 1, 2015

Record last verified: 2015-05

Locations